Hennessy Capital Acquisition Corp. IV (HCAC) is a special purpose acquisition company focused on merging with high-growth firms in the technology, healthcare, and consumer sectors. Backed by a seasoned management team, HCAC leverages its substantial financial resources and extensive industry connections to seek value-creating transactions. The company is well-positioned to tap into transformative market trends, presenting itself as a compelling investment opportunity for institutional investors looking to capture significant growth potential.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.23% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.13 |
| Price-to-Book | 100.36 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 236.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $29.80M |
| Float | $30.02M |
| % Insiders | 1.77% |
| % Institutions | 53.63% |
Volatility is currently contracting
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HCAC and any ticker you trade — then tracks every position and per-strategy win rate.